Symptom‐Based Clinical Deterioration as a Patient‐Centred Endpoint in Canine Urothelial Carcinoma

This multicentre retrospective cohort study operationalized structured clinical deterioration endpoints in canine urothelial carcinoma (UC) and compared them with conventional outcomes. A total of 182 dogs with imaging‐supported, cytologically and/or histopathologically confirmed UC from three referral institutions were included. Clinical signs were retrospectively mapped using prespecified grading rules anchored to VCOG‐CTCAE v2 and symptom‐based endpoints were defined from treatment initiation as time to lower urinary tract symptom progression (TTSP) and time to systemic deterioration (TTD), each assessed as initial (first grade ≥ 2 deterioration) and confirmed (grade ≥ 2 deterioration sustained at the next consecutive assessment) events. Imaging‐based progression‐free survival (PFS) was reconstructed from serial ultrasonography using VCOG cRECIST progression criteria (≥ 20% increase in longest tumour diameter or a new lesion). Confirmed TTSP and TTD were strongly associated with OS (rank correlations, 0.81 and 0.82, respectively) and remained prognostically informative in multivariable models and at most prespecified landmark times; the corresponding correlation for imaging‐based PFS was 0.74. TTSP/TTD were not temporally interchangeable with imaging‐based PFS or with acute kidney injury (AKI) and complete obstruction, showing broad individual‐level discordance and limited overlap even within ±7‐ and ±14‐day windows. In descriptive treatment‐group comparisons, patterns differed across OS, PFS and deterioration endpoints and in the rescue‐intervention subcohort, most dogs developed recurrent deterioration after decompression for malignant obstruction. These findings suggest that TTSP/TTD are feasible structured endpoints that capture clinically relevant and prognostically informative worsening not fully represented by imaging progression or catastrophic events alone.

Authors

Institutions

Publication Details

Journal
Veterinary and Comparative Oncology
Published
2026-11-19
DOI
https://doi.org/10.1111/vco.70132
Primary Topic
Veterinary Oncology Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Symptom‐Based Clinical Deterioration as a Patient‐Centred Endpoint in Canine Urothelial Carcinoma

Kyoung‐Won Seo, Min‐Ok Ryu, Yeon‐Jung Hong, Se-Hoon Kim et al.
Veterinary and Comparative Oncology
Veterinary Oncology Research
article

Symptom‐Based Clinical Deterioration as a Patient‐Centred Endpoint in Canine Urothelial Carcinoma

Kyoung‐Won Seo, Min‐Ok Ryu, Yeon‐Jung Hong, Se-Hoon Kim, Jin‐Kyung Kim, Junghoon Park, JiHyun Lim
article en

Abstract

This multicentre retrospective cohort study operationalized structured clinical deterioration endpoints in canine urothelial carcinoma (UC) and compared them with conventional outcomes. A total of 182 dogs with imaging‐supported, cytologically and/or histopathologically confirmed UC from three referral institutions were included. Clinical signs were retrospectively mapped using prespecified grading rules anchored to VCOG‐CTCAE v2 and symptom‐based endpoints were defined from treatment initiation as time to lower urinary tract symptom progression (TTSP) and time to systemic deterioration (TTD), each assessed as initial (first grade ≥ 2 deterioration) and confirmed (grade ≥ 2 deterioration sustained at the next consecutive assessment) events. Imaging‐based progression‐free survival (PFS) was reconstructed from serial ultrasonography using VCOG cRECIST progression criteria (≥ 20% increase in longest tumour diameter or a new lesion). Confirmed TTSP and TTD were strongly associated with OS (rank correlations, 0.81 and 0.82, respectively) and remained prognostically informative in multivariable models and at most prespecified landmark times; the corresponding correlation for imaging‐based PFS was 0.74. TTSP/TTD were not temporally interchangeable with imaging‐based PFS or with acute kidney injury (AKI) and complete obstruction, showing broad individual‐level discordance and limited overlap even within ±7‐ and ±14‐day windows. In descriptive treatment‐group comparisons, patterns differed across OS, PFS and deterioration endpoints and in the rescue‐intervention subcohort, most dogs developed recurrent deterioration after decompression for malignant obstruction. These findings suggest that TTSP/TTD are feasible structured endpoints that capture clinically relevant and prognostically informative worsening not fully represented by imaging progression or catastrophic events alone.

Veterinary and Comparative Oncology
Seoul National University (KR)
Veterinary Oncology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon